News

We interviewed Pfizer exec, Dr. Jonathan Rowe, about how they are leveraging predictive models to manage study risk and quality.

Examining the privacy of data and the mosaic effect in healthcare.

We discuss the pilot siteless models in clinical trial patient centricity with Gabriel Vargas, an executive at Amgen.

European experts in postmarking safety surveillance have the most to loose from impending EMA move post-Brexit.

Survey examines issues related to clinical trials quality and participation from the patients' view.

Q&A explores the implementation of the Trial Results Summaries Portal and the goals of the layperson summary program.

As Applied Clinical Trials celebrates its 25th birthday, longtime contributing author and columnist Ken Getz looks at the four truisms that still drive clinical trial operations today and into the future.

As our magazine embarks on the next 25 years of hopeful service covering the clinical trial enterprise, a quest for industry will be lessoning the complexity of drug development while remaining vigilant in protecting the patient.